The Food and Drug Administration on Tuesday approved an osteoporosis drug that represents the first new treatment approach in nearly two decades — a strategy based on a rare gene mutation in people ...
Recent trials have shown an increase in bone density with the device but have not shown a reduction in fracture rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback